Natural health product · NPN 80097768
LithoLyte
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed March 23, 2020; licence last revised June 25, 2024.
- Natural Product Number (NPN)
- 80097768
- Licence holder
- LithoLyte Corporation, LLC
- Dosage form
- Powder
- Route
- Oral
- Licensing route
- General (non-traditional)
- First licensed
- March 23, 2020
- Licence last revised
- June 25, 2024
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| Carbonic acid sodium salt (1:1) | 220 mg | Sodium bicarbonate; 60 mg Sodium |
| 2-Hydroxy-1,2,3-propanetricarboxylic acid tripotassium salt | 540 mg | Potassium citrate; 200 mg Potassium |
| 2-Hydroxy-1,2,3-propanetricarboxylic acid magnesium salt | 188 mg | Magnesium citrate; 30 mg Magnesium |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- Helps to prevent potassium deficiency (hypokalemia) due to low dietary intake. Contains citrate which helps support normal urinary citrate levels Contains citrate which helps support normal urinary pH Helps support healthy urinary citrate levels May increase urine citrate Helps increase urinary citrate LithoLyte is a source of dietary citrate An additive component to reduce the occurrence of kidney stones Citrate intake, when combined with adequate fluid intake, may reduce the risk of kidney stone formation Helps to support kidney health
Non-medicinal ingredients
Erythritol